Cellebrite DI (CLBT)
Software for accessing, analyzing, and managing evidence across legally sanctioned digital investigations.
Something off on this page? Send us feedback.
Supplies subscription software and services that access, decode, analyze, share, and manage digital evidence for legally sanctioned investigations. Its portfolio serves public-safety agencies, defense and intelligence organizations, and enterprises worldwide, with public-sector customers generating most revenue.
Provides software and services for legally sanctioned digital investigations. Inseyets accesses, extracts, and decodes evidence from phones, computers, cloud applications, vehicles, and other sources; Guardian manages evidence and case workflows, while Pathfinder and Genesis apply analytics and AI to surface connections and source-traced findings.
Corellium adds Arm-device virtualization for vulnerability research, malware analysis, and mobile-application testing; portable tools collect and decode UAV data. Cloud, on-premise, and hybrid offerings generate revenue through term licenses, SaaS subscriptions, maintenance, support, training, and advanced forensic services.
Maintains broad device and operating-system coverage through mobile research. Serves customers across the Americas, Europe, the Middle East and Africa, and Asia-Pacific, while public-sector agencies generate most revenue. Results depend on government procurement cycles, device-security changes, Israeli export controls, privacy rules, and lawful customer use.
Company facts
Categories
Target rangeAs of Sep 2, 2026
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Aug 14, 2026 | DA Davidson | Reiterate | Buy | $22 | $15 |
| Aug 14, 2026 | Lake Street | Reiterate | Buy | $21 | $15 |
| Aug 14, 2026 | Deutsche Bank | Target | $14 | ||
| Aug 14, 2026 | Needham | Reiterate | Buy | $15 | $12.50 |
| Aug 6, 2026 | DA Davidson | Reiterate | Buy | $20 | $22 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $442.5M · Total debt $23.2M · Total assets $994.3M · Shareholders' equity $538.1M
- Revenue
- $131.1M
- Operating income
- $7.6M
- Net income
- $6.4M
No dividends on record.
| Institutions213 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | ≈ 50.59% | 126.20M ADS | |
| Insiders18 holders · as of Aug 27, 2026 | 43.95% | 109.63M ADS | |
| Otherremainder | ≈ 5.46% | 13.61M ADS |
249.44M ADS as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
SuncorporationInsider | 42.52% | 106.07M | 13Gfiled Feb 24, 2026 ↗ |
True Wind Capital Management, L.P.Institution | 5.56% | 13.86M ADS | 13Fas of Jun 30, 2026 |
Voss Capital, LLCInstitution | 4.59% | 11.44M ADS | 13Fas of Jun 30, 2026 |
Pertento Partners LLPInstitution | 3.21% | 8.00M ADS | 13Fas of Jun 30, 2026 |
Phoenix Holdings Ltd.Institution | 2.48% | 6.18M ADS | 13Fas of Jun 30, 2026 |
| See all 25 → | |||
13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 25, 2026 | Thomas E. Hogan | other: Advisor | −25,299 | $11.29 |
| Aug 24, 2026 | David Nicholas Gee | officer: Chief Marketing Officer | −4,323 | $11.36 |
| Aug 21, 2026 | David Nicholas Gee | officer: Chief Marketing Officer | −2,198 | $11.24 |
| Aug 21, 2026 | Marcus Jewell | officer: Global Chief Revenue Officer | −12,562 | $11.24 |
| Aug 12, 2026 | Thomas E. Hogan | director, officer: Chief Executive Officer | −139,713 | $15.39 |
- Nexalin Technology
Investigative analytics for large, complex digital-data collections
- OpenText
Court-ready endpoint and mobile digital forensics
- NiCE (ADR)
Digital-evidence management for justice agencies
ComparePre-market
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Cellebrite DI | $11.55 | −0.56% | $2.90B | 49.7 | 28.8 | 5.6 | +15.8% |
| Nexalin Technology | $6.44 | +4.04% | $4.5M | — | — | 20.9 | −82.8% |
| OpenText | $23.58 | +0.11% | $5.72B | 5.2 | 6.0 | 0.6 | +1.6% |
| NiCE (ADR) | $107.75 | +0.80% | $6.26B | 15.5 | 9.0 | 2.0 | +7.7% |
| Median | 10.4 | 7.5 | 2.0 | +1.6% |